Cargando…

Differential Effects of Aripiprazole and Amisulpride on Negative and Cognitive Symptoms in Patients With First-Episode Psychoses

INTRODUCTION: Aripiprazole is hypothesized to have an effect on negative and cognitive symptoms in schizophrenia. Likewise, amisulpride is one of the only second-generation antipsychotics with which an effect on negative symptoms is reported. In the present study, we compare the effect of aripiprazo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nielsen, Mette Ødegaard, Kristensen, Tina Dam, Borup Bojesen, Kirsten, Glenthøj, Birte Y., Lemvigh, Cecilie K., Ebdrup, Bjørn H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969108/ https://www.ncbi.nlm.nih.gov/pubmed/35370857 http://dx.doi.org/10.3389/fpsyt.2022.834333

Ejemplares similares

S236. QUALITY OF LIFE AND ASSOCIATION WITH SYMPTOMS IN PATIENTS WITH SCHIZOPHRENIA SIX YEARS AFTER FIRST EPISODE PSYCHOSES
por: Andersen, Gitte, et al.
Publicado: (2020)

S150. DOPAMINE SYNTHESIS CAPACITY IN ANTIPSYCHOTIC NAïVE FIRST EPISODE PSYCHOTIC PATIENTS
por: Sigvard, Anne, et al.
Publicado: (2018)

Add-On MEmaNtine to Dopamine Antagonism to Improve Negative Symptoms at First Psychosis- the AMEND Trial Protocol
por: Sandström, Katharina O., et al.
Publicado: (2022)

Dopamine Synthesis Capacity and GABA and Glutamate Levels Separate Antipsychotic-Naïve Patients With First-Episode Psychosis From Healthy Control Subjects in a Multimodal Prediction Model
por: Sigvard, Anne K., et al.
Publicado: (2022)

Reward Processing as an Indicator of Vulnerability or Compensatory Resilience in Psychoses? Results From a Twin Study
por: Nielsen, Mette Ødegaard, et al.
Publicado: (2022)

Glutamate Levels and Resting Cerebral Blood Flow in Anterior Cingulate Cortex Are Associated at Rest and Immediately Following Infusion of S-Ketamine in Healthy Volunteers
por: Bojesen, Kirsten Borup, et al.
Publicado: (2018)

Cerebral blood flow in striatum is increased by partial dopamine agonism in initially antipsychotic-naïve patients with psychosis
por: Bojesen, Kirsten Borup, et al.
Publicado: (2023)

O9.5. NORMALIZATION OF DISTURBANCES IN PREDICTION ERROR IS RELATED TO TREATMENT RESPONSE AND RELATED TO THALAMIC GLUTAMATE LEVELS IN NON-RESPONDERS
por: Tangmose, Karen, et al.
Publicado: (2020)

Influence of psychopathology and metabolic parameters on quality of life in patients with first-episode psychosis before and after initial antipsychotic treatment
por: Dahl, Anne Sofie A., et al.
Publicado: (2023)

No Effects of Cognitive Remediation on Cerebral White Matter in Individuals at Ultra-High Risk for Psychosis—A Randomized Clinical Trial
por: Kristensen, Tina D., et al.
Publicado: (2020)

A nation-wide twin study of social cognition in schizophrenia spectrum disorders
por: Lemvigh, Cecilie K., et al.
Publicado: (2022)

F16. GLUTAMATE AND GABA LEVELS IN ANTIPSYCHOTIC-NAïVE SCHIZOPHRENIA PATIENTS ARE ASSOCIATED WITH TREATMENT OUTCOME AFTER 1.5 AND 6 MONTHS
por: Bojesen, Kirsten, et al.
Publicado: (2018)

Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
por: Giordano, Gloria, et al.
Publicado: (2020)

Lower Vitamin C Levels Are Associated With Less Improvement in Negative Symptoms in Initially Antipsychotic-Naïve Patients With First-Episode Psychosis
por: Myken, Anders N, et al.
Publicado: (2022)

S158. REWARD ALTERATIONS IN ANTIPSYCHOTIC NAïVE FIRST-EPISODE-PSYCHOSIS PATIENTS BEFORE AND AFTER TREATMENT WITH A PARTIAL DOPAMINE AGONIST
por: Tangmose, Karen, et al.
Publicado: (2018)

Scalability of the Positive and Negative Syndrome Scale in first‐episode schizophrenia assessed by Rasch models
por: Baandrup, Lone, et al.
Publicado: (2022)

Alterations of Intrinsic Connectivity Networks in Antipsychotic-Naïve First-Episode Schizophrenia
por: Anhøj, Simon, et al.
Publicado: (2018)

Substance-Induced Psychoses: An Updated Literature Review
por: Fiorentini, Alessio, et al.
Publicado: (2021)

Recurrent Episodes of Paraphilic Behavior Possibly Associated With Olanzapine and Aripiprazole Treatment in a Patient With Schizophrenia
por: Stefanou, Maria-Ioanna, et al.
Publicado: (2020)

Delusional Themes Across Affective and Non-Affective Psychoses
por: Picardi, Angelo, et al.
Publicado: (2018)

S215. FRONTO-TEMPORAL CEREBRAL BLOOD FLOW AND COGNITIVE FUNCTIONING IN PATIENTS WITH FIRST EPISODE PSYCHOSES TREATED WITH ARIPIPRAZOLE: PRELIMINARY FINDINGS
por: Peitl, Vjekoslav, et al.
Publicado: (2020)

M143. REGIONAL CEREBRAL BLOOD FLOW IN INITIALLY ANTIPSYCHOTIC-NAïVE PATIENTS WITH SCHIZOPHRENIA OR PSYCHOSIS: EFFECTS OF PARTIAL D2 RECEPTOR AGONISM AND ASSOCIATION WITH SYMPTOM IMPROVEMENT
por: Bojesen, Kirsten, et al.
Publicado: (2020)

Problematic Drug Use Among Outpatients With Schizophrenia and Related Psychoses
por: Chang, Sherilyn, et al.
Publicado: (2021)

Amisulpride withdrawal akathisia responding to aripiprazole with propranolol in first-onset psychosis: a case report
por: Yang, Hae-Jung, et al.
Publicado: (2022)

Case report: Amisulpride therapy induced reversible elevation of creatine kinase-MB and bradycardia in schizophrenia
por: Hu, Ze-Rui, et al.
Publicado: (2022)

Editorial: Early identification of affective and non-affective psychoses: From psychopathology to biomarkers
por: Fusar-Poli, Laura, et al.
Publicado: (2023)

S250. RELATION BETWEEN PSYCHOPATHOLOGY AND QUALITY OF LIFE IN SCHIZOPHRENIA PATIENTS BEFORE AND AFTER FIRST ANTIPSYCHOTIC TREATMENT
por: Andersen, Gitte, et al.
Publicado: (2018)

Associations Between Cognitive Function and Levels of Glutamatergic Metabolites and Gamma-Aminobutyric Acid in Antipsychotic-Naïve Patients With Schizophrenia or Psychosis
por: Bojesen, Kirsten Borup, et al.
Publicado: (2021)

Social Cognition Deficits as a Target of Early Intervention for Psychoses: A Systematic Review
por: Yamada, Yuji, et al.
Publicado: (2019)

Maternal Immune Activation and the Development of Dopaminergic Neurotransmission of the Offspring: Relevance for Schizophrenia and Other Psychoses
por: Aguilar-Valles, Argel, et al.
Publicado: (2020)

Aggression Amongst Outpatients With Schizophrenia and Related Psychoses in a Tertiary Mental Health Institution
por: Jeyagurunathan, Anitha, et al.
Publicado: (2022)

T60. GENETIC INFLUENCES ON MEMORY FUNCTIONS AND RELATED BRAIN STRUCTURES AND ASSOCIATIONS WITH SCHIZOPHRENIA SPECTRUM DISORDERS: A NATION-WIDE TWIN STUDY
por: Lemvigh, Cecilie, et al.
Publicado: (2020)

The Bridge Between Classical and “Synthetic”/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective
por: Orsolini, Laura, et al.
Publicado: (2019)

Neuromodulation to Treat Substance Use Disorders in People With Schizophrenia and Other Psychoses: A Systematic Review
por: Johnstone, Samantha, et al.
Publicado: (2022)

‘An experience of meaning’: A 20-year prospective analysis of delusional realities in schizophrenia and affective psychoses
por: Rosen, Cherise, et al.
Publicado: (2022)

Predicting symptom response and engagement in a digital intervention among individuals with schizophrenia and related psychoses
por: Price, George D., et al.
Publicado: (2022)

Optimizing subjective wellbeing with amisulpride in first episode schizophrenia or related disorders
por: de Haan, Lieuwe, et al.
Publicado: (2023)

Improving Knowledge on Pathways to Functional Outcome in Schizophrenia: Main Results From the Italian Network for Research on Psychoses
por: Giuliani, Luigi, et al.
Publicado: (2021)

Intuitive physics and intuitive psychology (“theory of mind”) in offspring of mothers with psychoses
por: Maróthi, Rebeka, et al.
Publicado: (2014)

Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial
por: Stabell, L.A, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_0f6l8v01tmq6lvch34c6bf455k